The Polymerase Chain Reaction Market is on a trajectory to redefine diagnostic processes in healthcare. As of 2024, the market is projected to reach USD 15.52 billion, reflecting a robust growth trend fueled by technological advancements and an increasing emphasis on rapid diagnostic solutions. Factors such as the rising prevalence of infectious diseases, which account for over 10 million...

The healthcare and biotechnology industries across North America are witnessing significant advancements in molecular diagnostics, driving the rapid expansion of the North America Digital PCR and Real-Time PCR Market. The increasing prevalence of infectious diseases, cancer, and genetic disorders has accelerated the demand for accurate and efficient diagnostic technologies. Digital PCR and...